F-STAR THERAPEUTICS INC's ticker is FSTX and the CUSIP is 30315R107. A total of 40 filers reported holding F-STAR THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $574,000 | -81.0% | 91,761 | -89.2% | 0.00% | -83.3% |
| Q1 2022 | $3,018,000 | -38.7% | 850,000 | -13.4% | 0.01% | -40.0% |
| Q4 2021 | $4,926,000 | -31.4% | 981,249 | 0.0% | 0.02% | -37.5% |
| Q3 2021 | $7,183,000 | -22.2% | 981,249 | -8.7% | 0.03% | -22.0% |
| Q2 2021 | $9,234,000 | +1037.2% | 1,075,000 | +1333.3% | 0.04% | +925.0% |
| Q1 2021 | $812,000 | – | 75,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ridgeback Capital Investments L.P. | 1,834,360 | $9,208,000 | 5.02% |
| DAFNA Capital Management LLC | 693,785 | $3,483,000 | 0.88% |
| Atlas Venture Advisors, Inc. | 574,996 | $2,886,000 | 0.40% |
| Atlas Venture Life Science Advisors, LLC | 599,524 | $3,010,000 | 0.28% |
| Anson Funds Management LP | 309,703 | $1,555,000 | 0.15% |
| Connolly Sarah T. | 53,001 | $266,000 | 0.15% |
| Rock Springs Capital Management LP | 751,889 | $3,774,000 | 0.09% |
| Point72 Asset Management, L.P. | 981,249 | $4,926,000 | 0.02% |
| Eversept Partners, LP | 49,933 | $250,664 | 0.02% |
| Private Capital Advisors, Inc. | 13,083 | $66,000 | 0.01% |